当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析

昆药集团

(600422)

  

流通市值:88.64亿  总市值:88.64亿
流通股本:7.57亿   总股本:7.57亿

昆药集团(600422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润4.19亿元,每股收益0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益694140.46万元,未分配利润373470.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产1177356.44万元,负债483215.98万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入6,575,214,133.554,751,206,077.583,351,347,279.451,608,452,032.42
营业总成本6,335,560,770.884,530,354,855.673,100,213,351.061,490,477,668.68
其他经营收益
营业利润448,507,950.06379,298,300.11299,803,982.41148,463,945.82
利润总额473,557,838.67378,421,050.69298,940,268.97149,103,911.43
净利润419,052,861.68323,404,751.99249,920,820.76113,552,441.59
每股收益
其他综合收益-12,037,693.6229,191.861,987,515.851,281,044.33
综合收益总额407,015,168.06323,433,943.85251,908,336.61114,833,485.92
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计7,723,739,881.557,961,178,600.978,635,256,590.098,680,727,395.48
非流动资产:
非流动资产合计4,049,824,526.94,044,953,367.664,022,532,237.034,023,796,766.21
资产总计11,773,564,408.4512,006,131,968.6312,657,788,827.1212,704,524,161.69
流动负债:
流动负债合计3,825,689,164.74,123,871,040.54,861,855,581.84,751,158,437.54
非流动负债:
非流动负债合计1,006,470,657.091,026,542,116.531,024,850,060.871,092,264,663.29
负债合计4,832,159,821.795,150,413,157.035,886,705,642.675,843,423,100.83
所有者权益(或股东权益):
归属于母公司股东权益合计5,362,259,636.545,308,840,393.435,226,959,645.615,345,426,198.41
股东权益合计6,941,404,586.666,855,718,811.66,771,083,184.456,861,101,060.86
负债和股东权益合计11,773,564,408.4512,006,131,968.6312,657,788,827.1212,704,524,161.69
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计7,500,547,034.085,656,393,363.533,986,161,434.831,707,090,079.82
经营活动现金流出小计7,211,310,931.285,480,229,696.293,767,330,478.481,846,536,508.55
经营活动产生的现金流量净额289,236,102.8176,163,667.24218,830,956.35-139,446,428.73
投资活动产生的现金流量:
投资活动现金流入小计5,345,256,380.82,643,845,819.31,294,842,286.96626,227,207.71
投资活动现金流出小计5,982,259,480.974,118,725,860.542,657,025,967.731,669,948,028.73
投资活动产生的现金流量净额-637,003,100.17-1,474,880,041.24-1,362,183,680.77-1,043,720,821.02
筹资活动产生的现金流量:
筹资活动现金流入小计1,756,208,570.611,392,199,133.631,253,539,493.46953,621,441.38
筹资活动现金流出小计2,410,844,094.491,506,012,944.111,099,931,735.21826,712,667.75
筹资活动产生的现金流量净额-654,635,523.88-113,813,810.48153,607,758.25126,908,773.63
汇率变动对现金及现金等价物的影响-534,546.4711,822.521,028,421.1235,093.62
现金及现金等价物净增加额-1,002,937,067.65-1,411,818,361.96-988,716,545.05-1,056,223,382.5
期末现金及现金等价物余额1,130,987,344.12722,106,049.811,145,207,866.721,077,701,029.27
补充资料:
现金及现金等价物的净增加额-1,002,937,067.65--988,716,545.05-
最新报告期:2026-03-20
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国金证券王奔奔,甘坛焕0.280.460.662026-03-20
中国银河程培,宋丽莹0.510.660.792026-03-20
平安证券叶寅,曹艳凯0.630.83--2026-03-09
TOP↑